Sample of synthetic peptide vaccine SPf66, developed by Dr Manuel Elkin Patarroyo and collaborators as a synthetic vaccine for malaria, Bogota, Colombia, with placebo, as used in the Phase III randomised, double-blind, placebo controlled trial at La Tola, Colombia, 1992. (The Lancet, 20 March 1993)
Cite this page
We encourage the use and reuse of our collection data.
Data in the title, made, maker and details fields are released under Creative Commons Zero
Descriptions and all other text content are licensed under a Creative Commons Attribution 4.0 licence
Download catalogue entry as json
View manifest in IIIF viewer
Download manifest IIIF
Our records are constantly being enhanced and improved, but please note that we cannot guarantee the accuracy of any information shown on this website.